Your session is about to expire
← Back to Search
A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver Tumors
N/A
Waitlist Available
Led By Michael D'Angelica
Research Sponsored by Memorial Sloan Kettering Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group
Summary
The purpose of this study is to explore novel ways of diagnosing colon cancer and predicting its propensity to spread to other organs such as the liver.
Eligible Conditions
- Liver Cancer
- Colon Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
successful isolation of exosomes
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
4Treatment groups
Experimental Treatment
Group I: presumptive Stage II or III colon cancerExperimental Treatment3 Interventions
Group II: Stage IV colon cancer with unresectable hepatic metastasesExperimental Treatment3 Interventions
Group III: Stage IV colon cancer with resectable hepatic metastasesExperimental Treatment3 Interventions
Group IV: Stage I colon cancer, pre-neoplastic or benign colon lesionsExperimental Treatment2 Interventions
Find a Location
Who is running the clinical trial?
Memorial Sloan Kettering Cancer CenterLead Sponsor
1,979 Previous Clinical Trials
599,787 Total Patients Enrolled
21 Trials studying Liver Cancer
7,803 Patients Enrolled for Liver Cancer
Weill Medical College of Cornell UniversityOTHER
1,092 Previous Clinical Trials
1,154,735 Total Patients Enrolled
1 Trials studying Liver Cancer
582 Patients Enrolled for Liver Cancer
Michael D'AngelicaPrincipal InvestigatorMemorial Sloan Kettering Cancer Center